Treatment principles for the management of mold infections

Dimitrios P Kontoyiannis1, Russell E Lewis2

  • 1The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030.

Insights

Survival rates for invasive mold infections in immunocompromised patients have improved due to earlier diagnosis and new antifungal treatments. However, challenges like antifungal resistance and treatment side effects necessitate individualized management plans.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Management

Background:

  • Invasive mold infections pose significant risks to immunocompromised patients.
  • Advances in diagnosis and antifungal therapies have improved survival rates.
  • Antifungal resistance, breakthrough infections, and treatment toxicities present ongoing challenges.

Purpose of the Study:

  • To outline key principles for managing invasive mold diseases in immunocompromised individuals.
  • To guide the integration of these principles into individualized treatment strategies.

Main Methods:

  • Review of current evidence-based recommendations for invasive aspergillosis and mucormycosis.
  • Discussion of 10 general treatment principles for invasive mold disease.
  • Emphasis on integrating principles for personalized patient care.

Main Results:

  • Improved survival with earlier diagnosis and novel antifungal agents.
  • Increasing concerns regarding antifungal resistance and drug-related adverse events.
  • Need for comprehensive management strategies beyond initial treatment guidelines.

Conclusions:

  • Effective management of invasive mold disease requires addressing challenges like resistance and toxicity.
  • Individualized treatment plans are crucial for optimizing outcomes in immunocompromised patients.
  • Adherence to 10 general treatment principles can enhance patient care and survival rates.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
656
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
947
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.4K